Scientists have shown that boosting the protein Sox9 in astrocytes can activate a receptor called MEGF10, enabling these brain support cells to engulf and clear existing amyloid plaques in Alzheimer’s ...
New research in Spain could change the future treatment of osteoarthritis.
ME Therapeutics Holdings Inc. ("ME Therapeutics" or the "Company") (CSE: METX) (FSE: Q9T), a publicly listed biotechnology ...
GC Therapeutics (GCTx), a pioneering biotechnology company advancing the next generation of cell-based medicines through its TFomeâ„¢ (Transcription-Factor-ome) induced pluripotent stem cell (iPSC) ...
Years before he conducted the research that would earn him a Nobel Prize in Physiology and Medicine, Shinya Yamanaka, MD, ...
New York Blood Center Enterprises’ (NYBCe) Lindsley F. Kimball Research Institute (LFKRI) today announced a scientific collaboration with Biohub to develop optimized methodologies for deriving induced ...
Scientists from Trinity College Dublin and RCSI University of Medicine and Health Sciences have created new "hybrid" immune ...
Cancer incidence rises sharply with age, yet the biological mechanisms that make older patients more vulnerable to treatment failure remain poorly ...
A clinical trial to reverse age-related vision conditions using stem cell treatment could finally deliver on the promise of a ...
Cancer immunology is advancing rapidly as researchers seek to unravel the complex, dynamic relationships between tumor cells, immune populations, and the ...
Scientists used a bacterial system called retron to turn DNA into a programmable tool inside living cells, enabling gene regulation and disease detection. The non-genetic DNA platform leverages a ...